{"meta":{"query_hash":"a7d8020ec65c","filters":{"venue":"Investigations in Gynecology Research & Womens Health (IGRWH)"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a7d8020ec65c","api":"https://metacan.xera.ac/api/v1/cohort?venue=Investigations+in+Gynecology+Research+%26+Womens+Health+%28IGRWH%29"},"results":[{"id":"W2884237425","doi":"10.31031/igrwh.2018.01.000524","title":"Humanized GHR106 Monoclonal Antibody is a Biosimilar GnRH Antagonist","year":2018,"lang":"en","type":"article","venue":"Investigations in Gynecology Research & Womens Health (IGRWH)","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Monoclonal antibody; Biosimilar; Antibody; Antagonist; Receptor; Humanized antibody; Chemistry; Isotype; Immunohistochemistry; Molecular biology; Peptide; Pharmacology; Cancer research; Biology; Internal medicine; Immunology; Medicine; Biochemistry","score_opus":0.054101737577323304,"score_gpt":0.4277143456931328,"score_spread":0.37361260811580954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884237425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8921689,0.023884162,0.03226691,0.0015013008,0.0008765955,0.0008763643,0.001904901,0.001123087,0.045397915],"genre_scores_gemma":[0.95173526,0.0047080885,0.019668918,0.000728568,0.00016496153,0.00020948668,0.0027653326,0.00008141227,0.019937955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996904,0.000063988104,0.000020695452,0.000061646366,0.00012648903,0.00003676259],"domain_scores_gemma":[0.9998845,0.000020832054,0.000022435295,0.00001780895,0.000026132539,0.000028290688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034559288,0.00026922772,0.00025216315,0.0003554686,0.00013579152,0.00024493027,0.00038096998,0.0004910488,0.003968847],"category_scores_gemma":[0.00030183778,0.00011498347,0.00031462568,0.00022556706,0.00023874125,0.00019529687,0.00025058186,0.00063995854,0.0011354641],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007227617,0.00019868575,0.0005231015,0.0001894743,0.000024796776,0.00038425362,0.000050496154,0.00018383894,0.9419452,0.0008875851,0.0015603733,0.053329397],"study_design_scores_gemma":[0.0006668838,0.0076270024,0.008399578,0.000059779446,0.000113250026,0.010203084,0.000075749114,0.0014031441,0.77732205,0.0005223403,0.19356278,0.000044331242],"about_ca_topic_score_codex":0.00047724615,"about_ca_topic_score_gemma":0.000383785,"teacher_disagreement_score":0.003968847,"about_ca_system_score_codex":0.0004092917,"about_ca_system_score_gemma":0.00025707064,"threshold_uncertainty_score":0.013277054},"labels":[],"label_agreement":null}]}